❣️The Fall 2025 issue of the CVC Chronicle newsletter is now available❣️

Read about our current trials, research highlights, & other recent news/updates here: tinyurl.com/3w4srx67

New analysis published in @jcardfail.bsky.social: applying the 5-STAR risk stratification method to VICTORIA trial data revealed a greater treatment effect for vericiguat on the composite endpoint of CV death or HF hospitalization.

Read more ➡️: authors.elsevier.com/a/1llYy3pkRz...

The AURORA study is currently recruiting adults & adolescents with type 1 diabetes (T1D) & caregivers for an advisory group. Share your experience navigating the Alberta healthcare system & help us create a vital T1D knowledge hub!

Learn more ➡️: thecvc.ca/aurora-recru...

New in @jaccjournals.bsky.social: A secondary analysis of the VICTORIA trial investigates the impact of geographic variation and Human Development Index on heart failure outcomes. 🫀 🌏

Read more here: www.sciencedirect.com/science/arti...

❣️The Spring 2025 issue of the CVC Chronicle newsletter is now available ❣️

Read about our current trials, research highlights, & other recent news/updates here: mailchi.mp/3fed258d1c05...

New research: Women with asthma, particularly active asthma, are at higher risk for preterm birth, low birth weight, & C-section. These findings highlight the need for improved asthma monitoring & management during pregnancy. @wchriuofa.bsky.social

Read here: www.sciencedirect.com/science/arti...

We are pleased to share our 2024 Annual Report: ⚙️Research in Motion⚙️

The CVC is committed to advancing cardiovascular research, recognizing that each step in the process drives meaningful developments & enhances health outcomes for current & future generations.

Read here: thecvc.ca/2024-annual-...